Pliant Therapeutics Ownership | Who Owns Pliant Therapeutics?

Pliant Therapeutics Ownership Summary

Pliant Therapeutics is owned by 83.85% institutional investors, 3.04% insiders, and 13.11% retail investors. Tang capital management is the largest institutional shareholder, holding 9.77% of PLRX shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 3.84% of its assets in Pliant Therapeutics shares.

PLRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pliant Therapeutics	83.85%	3.04%	13.11%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tang capital management	6.00M	9.77%	$6.96M
Blackrock	4.97M	8.26%	$53.45M
Price t rowe associates inc /md/	4.63M	7.63%	$61.04M
Deep track capital, lp	3.95M	6.43%	$4.58M
Fmr	3.88M	6.38%	$51.05M
Vanguard group	3.23M	5.32%	$42.52M
Blue owl capital lp	2.97M	4.84%	$3.44M
Trv gp iv	2.13M	3.47%	$2.47M
Blackrock funding, inc. /de	2.13M	3.47%	$2.47M
Redmile group	1.63M	2.66%	$1.89M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Mass general brigham	288.69K	15.11%	$3.10M
Fernwood investment management	425.42K	1.95%	$5.60M
Trv gp iv	2.13M	1.51%	$2.47M
Blue owl capital lp	2.97M	1.11%	$3.44M
Great point partners	850.00K	0.64%	$986.00K
Tang capital management	6.00M	0.35%	$6.96M
Prosight management, lp	837.40K	0.24%	$971.38K
Rock springs capital management lp	404.80K	0.20%	$5.33M
Redmile group	1.63M	0.20%	$1.89M
Deep track capital, lp	3.95M	0.15%	$4.58M

Top Buyers

Holder	Shares	% Assets	Change
Monaco asset management sam	702.39K	0.14%	702.39K
Prosight management, lp	837.40K	0.24%	503.14K
Acadian asset management	1.63M	0.00%	409.97K
Ubs group	628.28K	0.00%	397.97K
Blackrock	4.97M	0.00%	316.25K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-3.20M
Blackrock funding, inc. /de	2.13M	-	-3.11M
Cormorant asset management, lp	-	-	-3.00M
Laurion capital management lp	-	-	-2.50M
Polar capital	-	-	-2.02M

New Positions

Holder	Shares	% Assets	Change	Value
Monaco asset management sam	702.39K	0.14%	702.39K	$814.78K
Qube research	151.66K	0.00%	151.66K	$175.93K
Point72 asia (singapore) pte.	48.01K	0.01%	48.01K	$55.69K
Hrt financial lp	32.48K	0.00%	32.48K	$37.00K
Canada pension plan investment board	30.80K	-	30.80K	$35.73K

Sold Out

Holder	Change
Allworth financial lp	-2.00
Mine & arao wealth creation & management, llc.	-2.00
National bank of canada /fi/	-8.00
Nelson, van denburg & campbell wealth management group	-11.00
Larson financial group	-15.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	115	-18.44%	51,469,896	-10.18%	83	0.96%	51	-31.08%	40	2.56%
Mar 31, 2025	142	-13.41%	57,894,025	-10.59%	94	0.83%	75	-5.06%	39	-4.88%
Dec 31, 2024	70	-55.70%	15,788,963	-75.13%	25	0.24%	37	-54.88%	12	-62.50%
Sep 30, 2024	158	6.76%	63,495,937	-0.63%	104	0.93%	83	6.41%	31	-6.06%
Jun 30, 2024	148	4.96%	63,899,831	-1.97%	106	0.91%	78	21.88%	33	-10.81%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	2.34M	3.84%	-75.06K
T. Rowe Price New Horizons	2.34M	3.82%	-676.00
DWS ESG Akkumula LC	2.30M	3.76%	-4.00
Vanguard US Total Market Shares ETF	2.03M	3.32%	-
Polar Capital Biotech S Inc	1.85M	3.02%	-
Fidelity Growth Compy Commingled Pl S	1.82M	2.96%	-
Fidelity Growth Compy Commingled Pl O	1.77M	2.91%	-
Vanguard Total Stock Mkt Idx Inv	1.75M	2.85%	-38.65K
Fidelity Growth Company Fund	1.29M	2.11%	-2.64K
Candriam Eqs L Biotech C USD Cap	900.10K	1.47%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 17, 2025	Coulie Bernard	President and CEO	Sell	$587.15K
Jan 17, 2025	Cummings Keith Lamont	Chief Financial Officer	Sell	$225.68K
Jan 17, 2025	Hull Hans	Chief Business Officer	Sell	$178.50K
Jan 17, 2025	Lefebvre Eric	Chief Medical Officer	Sell	$206.97K
Jan 17, 2025	Cheung Lily	Chief Human Resource Officer	Sell	$41.89K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	7
2024 Q3	-	5
2024 Q2	-	-
2024 Q1	-	5
2023 Q3	-	9

PLRX Ownership FAQ

Who Owns Pliant Therapeutics?

Pliant Therapeutics shareholders are primarily institutional investors at 83.85%, followed by 3.04% insiders and 13.11% retail investors. The average institutional ownership in Pliant Therapeutics's industry, Biotech Stocks , is 306.59%, which Pliant Therapeutics falls below.

Who owns the most shares of Pliant Therapeutics?

Pliant Therapeutics’s largest shareholders are Tang capital management (6M shares, 9.77%), Blackrock (4.97M shares, 8.26%), and Price t rowe associates inc /md/ (4.63M shares, 7.63%). Together, they hold 25.67% of Pliant Therapeutics’s total shares outstanding.

Does Blackrock own Pliant Therapeutics?

Yes, BlackRock owns 8.26% of Pliant Therapeutics, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 53.45M$. In the last quarter, BlackRock increased its holdings by 316.25K shares, a 6.79% change.

Who is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested?

Mass general brigham is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.11% of its assets in 288.69K Pliant Therapeutics shares, valued at 3.1M$.

Who is the top mutual fund holder of Pliant Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Pliant Therapeutics shares, with 3.84% of its total shares outstanding invested in 2.34M Pliant Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools